Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIRCH: Ir-CPI in Spontaneous Intracerebral Haemorrhage
2022-500491-53-00Phase 2Completed
- Sponsor
- Bioxodes
- Start
- Feb 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in intracerebral hemorrhage (ICH) comparing Ir-CPI plus standard of care with Standard of care alone (2 arms). Primary endpoints: Safety and tolerability (adverse events and serious adverse events), Electrocardiograms (ECGs) and 4 more. Started Feb 2023; status: completed.
02
Drugs
BIOX-101
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on 2022-500491-53-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-500491-53-00.